X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs AJANTA PHARMA - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA AJANTA PHARMA TORRENT PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 25.0 20.3 123.2% View Chart
P/BV x 6.1 8.8 69.7% View Chart
Dividend Yield % 3.3 0.7 477.1%  

Financials

 TORRENT PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
AJANTA PHARMA
Mar-16
TORRENT PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7201,720 100.0%   
Low Rs1,1341,103 102.8%   
Sales per share (Unadj.) Rs394.5194.6 202.7%  
Earnings per share (Unadj.) Rs101.845.2 225.1%  
Cash flow per share (Unadj.) Rs116.350.3 231.3%  
Dividends per share (Unadj.) Rs40.008.00 500.0%  
Dividend yield (eoy) %2.80.6 494.7%  
Book value per share (Unadj.) Rs200.3132.0 151.7%  
Shares outstanding (eoy) m169.2288.77 190.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.67.3 49.9%   
Avg P/E ratio x14.031.2 44.9%  
P/CF ratio (eoy) x12.328.1 43.7%  
Price / Book Value ratio x7.110.7 66.6%  
Dividend payout %39.317.7 222.1%   
Avg Mkt Cap Rs m241,435125,299 192.7%   
No. of employees `00010.9NA-   
Total wages/salary Rs m8,5592,570 333.0%   
Avg. sales/employee Rs Th6,129.6NM-  
Avg. wages/employee Rs Th785.8NM-  
Avg. net profit/employee Rs Th1,581.3NM-  
INCOME DATA
Net Sales Rs m66,76417,275 386.5%  
Other income Rs m2,156166 1,296.7%   
Total revenues Rs m68,92017,442 395.1%   
Gross profit Rs m27,2045,807 468.4%  
Depreciation Rs m2,461451 546.1%   
Interest Rs m1,85949 3,801.0%   
Profit before tax Rs m25,0415,474 457.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1,4030-   
Tax Rs m6,4141,460 439.3%   
Profit after tax Rs m17,2244,014 429.1%  
Gross profit margin %40.733.6 121.2%  
Effective tax rate %25.626.7 96.0%   
Net profit margin %25.823.2 111.0%  
BALANCE SHEET DATA
Current assets Rs m46,6227,639 610.3%   
Current liabilities Rs m32,8432,715 1,209.8%   
Net working cap to sales %20.628.5 72.4%  
Current ratio x1.42.8 50.4%  
Inventory Days Days7443 171.8%  
Debtors Days Days7979 100.4%  
Net fixed assets Rs m39,0296,914 564.5%   
Share capital Rs m846177 478.3%   
"Free" reserves Rs m31,40011,442 274.4%   
Net worth Rs m33,89011,721 289.2%   
Long term debt Rs m18,637149 12,533.2%   
Total assets Rs m90,13614,814 608.4%  
Interest coverage x14.5112.9 12.8%   
Debt to equity ratio x0.50 4,334.5%  
Sales to assets ratio x0.71.2 63.5%   
Return on assets %21.227.4 77.2%  
Return on equity %50.834.2 148.4%  
Return on capital %48.546.5 104.3%  
Exports to sales %43.355.1 78.6%   
Imports to sales %6.96.0 114.3%   
Exports (fob) Rs m28,9349,527 303.7%   
Imports (cif) Rs m4,5841,038 441.8%   
Fx inflow Rs m29,18510,422 280.0%   
Fx outflow Rs m6,0211,678 358.8%   
Net fx Rs m23,1658,744 264.9%   
CASH FLOW
From Operations Rs m27,1323,264 831.3%  
From Investments Rs m-7,014-2,093 335.1%  
From Financial Activity Rs m-14,352-1,186 1,210.4%  
Net Cashflow Rs m5,767-15 -38,962.8%  

Share Holding

Indian Promoters % 71.5 73.8 96.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 1.6 452.9%  
FIIs % 12.6 7.6 165.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 17.0 51.8%  
Shareholders   26,511 20,968 126.4%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   BIOCON LTD  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  FDC LTD.  

Compare TORRENT PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 23, 2017 09:58 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS